Literature DB >> 33986169

Preventing respiratory syncytial virus (RSV) disease in children.

Ruth A Karron1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33986169     DOI: 10.1126/science.abf9571

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

Review 1.  Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children.

Authors:  Zhe Zheng
Journal:  Yale J Biol Med       Date:  2022-06-30

2.  Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults.

Authors:  Ruth A Karron; Maria Garcia Quesada; Elizabeth A Schappell; Stephen D Schmidt; Maria Deloria Knoll; Marissa K Hetrich; Vic Veguilla; Nicole Doria-Rose; Fatimah S Dawood
Journal:  JCI Insight       Date:  2022-04-22

3.  WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.

Authors:  Erin Sparrow; Ifedayo Adetifa; Nathorn Chaiyakunapruk; Thomas Cherian; Deshayne B Fell; Barney S Graham; Bruce Innis; David C Kaslow; Ruth A Karron; Harish Nair; Kathleen M Neuzil; Samir Saha; Peter G Smith; Padmini Srikantiah; Fred Were; Heather J Zar; Daniel Feikin
Journal:  Vaccine       Date:  2022-02-17       Impact factor: 4.169

4.  Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample.

Authors:  Mina Suh; Naimisha Movva; Xiaohui Jiang; Lauren C Bylsma; Heidi Reichert; Jon P Fryzek; Christopher B Nelson
Journal:  J Infect Dis       Date:  2022-08-15       Impact factor: 7.759

5.  Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.

Authors:  Naimisha Movva; Mina Suh; Lauren C Bylsma; Jon P Fryzek; Christopher B Nelson
Journal:  J Infect Dis       Date:  2022-08-15       Impact factor: 7.759

6.  Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.

Authors:  Mina Suh; Naimisha Movva; Xiaohui Jiang; Heidi Reichert; Lauren C Bylsma; Jon P Fryzek; Christopher B Nelson
Journal:  J Infect Dis       Date:  2022-08-15       Impact factor: 7.759

7.  Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication.

Authors:  Tatyana M Khomenko; Anna A Shtro; Anastasia V Galochkina; Yulia V Nikolaeva; Galina D Petukhova; Sophia S Borisevich; Dina V Korchagina; Konstantin P Volcho; Nariman F Salakhutdinov
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.